TY - JOUR T1 - Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series JF - medRxiv DO - 10.1101/2020.04.20.20072116 SP - 2020.04.20.20072116 AU - Michael G Argenziano AU - Samuel L Bruce AU - Cody L Slater AU - Jonathan R Tiao AU - Matthew R Baldwin AU - R Graham Barr AU - Bernard P Chang AU - Katherine H Chau AU - Justin J Choi AU - Nicholas Gavin AU - Parag Goyal AU - Angela M Mills AU - Ashmi A Patel AU - Marie-Laure S Romney AU - Monika M. Safford AU - Neil W Schluger AU - Soumitra Sengupta AU - Magdalena E Sobieszczyk AU - Jason E Zucker AU - Paul A Asadourian AU - Fletcher M Bell AU - Rebekah Boyd AU - Matthew F Cohen AU - MacAlistair I Colquhoun AU - Lucy A Colville AU - Joseph H de Jonge AU - Lyle B Dershowitz AU - Shirin A Dey AU - Katherine A Eiseman AU - Zachary P Girvin AU - Daniella T Goni AU - Amro A Harb AU - Nicholas Herzik AU - Sarah Householder AU - Lara E Karaaslan AU - Heather Lee AU - Evan Lieberman AU - Andrew Ling AU - Ree Lu AU - Arthur Y Shou AU - Alexander C Sisti AU - Zachary E Snow AU - Colin P Sperring AU - Yuqing Xiong AU - Henry W Zhou AU - Karthik Natarajan AU - George Hripcsak AU - Ruijun Chen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/07/2020.04.20.20072116.abstract N2 - Objective To characterize patients with coronavirus disease 2019 (COVID-19) in a large New York City (NYC) medical center and describe their clinical course across the emergency department (ED), inpatient wards, and intensive care units (ICUs).Design Retrospective manual medical record review.Setting NewYork-Presbyterian/Columbia University Irving Medical Center (NYP/CUIMC), a quaternary care academic medical center in NYC.Participants The first 1000 consecutive patients with laboratory-confirmed COVID-19.Methods We identified the first 1000 consecutive patients with a positive RT-SARS-CoV-2 PCR test who first presented to the ED or were hospitalized at NYP/CUIMC between March 1 and April 5, 2020. Patient data was manually abstracted from the electronic medical record.Main outcome measures We describe patient characteristics including demographics, presenting symptoms, comorbidities on presentation, hospital course, time to intubation, complications, mortality, and disposition.Results Among the first 1000 patients, 150 were ED patients, 614 were admitted without requiring ICU-level care, and 236 were admitted or transferred to the ICU. The most common presenting symptoms were cough (73.2%), fever (72.8%), and dyspnea (63.1%). Hospitalized patients, and ICU patients in particular, most commonly had baseline comorbidities including of hypertension, diabetes, and obesity. ICU patients were older, predominantly male (66.9%), and long lengths of stay (median 23 days; IQR 12 to 32 days); 78.0% developed AKI and 35.2% required dialysis. Notably, for patients who required mechanical ventilation, only 4.4% were first intubated more than 14 days after symptom onset. Time to intubation from symptom onset had a bimodal distribution, with modes at 3-4 and 9 days. As of April 30, 90 patients remained hospitalized and 211 had died in the hospital.Conclusions Hospitalized patients with COVID-19 illness at this medical center faced significant morbidity and mortality, with high rates of AKI, dialysis, and a bimodal distribution in time to intubation from symptom onset.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding organization or sponsor was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequests for the statistical code and dataset can be made to the corresponding author. ER -